Medimmune Llc

This study is testing whether an immunotherapy drug called tremelimumab can help people with advanced mesothelioma live longer when standard treatments have stopped working. About 571 patients whose cancer cannot be removed by surgery will receive either tremelimumab or a placebo…

This early-stage study is testing the safety and effectiveness of new two-drug combinations for people with advanced non-small cell lung cancer that has a specific genetic change (EGFR mutation) and has stopped responding to previous treatments. The trial enrolled 43 participants…

This study is testing whether adding new, experimental drugs to standard chemotherapy can better control advanced colorectal cancer that has spread. It involves 61 adults with a specific type of colorectal cancer who have not yet received treatment for their advanced disease. The…

This study tested several immunotherapy drugs, alone and in combination, for people with advanced liver cancer that had stopped responding to standard treatment. The main goals were to see if the treatments were safe and if they could help control the cancer. Researchers enrolled…